Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News Galena Biopharma GALE

Healthcare Biotechnology
"Galena Biopharma is a biopharmaceutical company. Its main activity is the development and commercialization of hematology and oncology therapies. Its pipeline includes products targeting hematology diseases, breast cancer, gastric cancer, and gynecological cancer. The company’s cancer immunotherapy consists of two areas: prevention of cancer reoccurrence and primary prevention of invasive... see more

Recent & Breaking News (NDAQ:GALE)

Galena Biopharma Announces Pricing of Public Offering of Common Stock and Warrants

GlobeNewswire February 8, 2017

Galena Biopharma Announces Proposed Public Offering of Common Stock and Warrants

GlobeNewswire February 7, 2017

Trump's Intentions to Streamline Drug-Approval Process Fueling Biotech Optimism

PR Newswire Europe Non Regulatory February 7, 2017

Mid-Afternoon Market Update: Hasbro Surges On Earnings Beat; Aratana Therapeutics Shares Slide

Benzinga.com  February 6, 2017

15 Biggest Mid-Day Gainers For Monday

Benzinga.com  February 6, 2017

Mid-Morning Market Update: Markets Edge Lower; Tyson Tops Q1 Estimates

Benzinga.com  February 6, 2017

Galena Biopharma Reports Positive Outcome from the Data Safety Monitoring Board on the Two NeuVax™ (nelipepimut-S) Clinical Trials in Combination with Trastuzumab

GlobeNewswire February 6, 2017

20 Biggest Mid-Day Losers For Wednesday

Benzinga.com  February 1, 2017

Mid-Morning Market Update: Markets Open Higher; Apple Tops Q1 Expectations

Benzinga.com  February 1, 2017

Galena Biopharma Announces the Resignation of its President and Chief Executive Officer and the Evaluation of Strategic Alternatives

GlobeNewswire January 31, 2017

Technical Reports on Biotech Stocks -- Clovis Oncology, Galena Biopharma, and ACADIA Pharma

PR Newswire January 13, 2017

15 Stocks Moving In Monday's Pre-Market Session

Benzinga.com  January 9, 2017

Galena Biopharma to Provide Corporate and Clinical Update and 2017 Outlook During Presentation at Biotech Showcase 2017

GlobeNewswire January 5, 2017

Mid-Afternoon Market Update: Dow Falls Over 100 Points; Kate Spade Gains Amid M&A Speculation

Benzinga.com  December 28, 2016

Mid-Day Market Update: Anthera Pharma Drops On Disappointing Phase 3 Data; Ocera Therapeutics Shares Surge

Benzinga.com  December 28, 2016

Mid-Morning Market Update: Markets Down; Galena Shares Surge On Regulatory Pathway For Thrombosis Treatment

Benzinga.com  December 28, 2016

Galena Shares Up 50% On Regulatory Pathway For Thrombosis Treatment

Benzinga.com  December 28, 2016

Galena Biopharma Confirms Regulatory Pathway for GALE-401 (Anagrelide Controlled Release)

GlobeNewswire December 28, 2016

Galena Biopharma Announces the Phase 2 Clinical Trial of NeuVax™ (nelipepimut-S) in Ductal Carcinoma in Situ (DCIS) is Open for Enrollment and Screening Patients

GlobeNewswire December 14, 2016

Galena Biopharma Inc. Presentation Now Available for On-Demand Viewing

PR Newswire December 5, 2016